Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,529 | 73 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $359.14 | 18 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $343.71 | 20 | $0 (2024) |
| AbbVie Inc. | $157.12 | 6 | $0 (2023) |
| Amgen Inc. | $92.44 | 3 | $0 (2024) |
| Exact Sciences Corporation | $90.01 | 4 | $0 (2024) |
| Astellas Pharma US Inc | $73.29 | 3 | $0 (2024) |
| GlaxoSmithKline, LLC. | $48.07 | 2 | $0 (2024) |
| PFIZER INC. | $45.63 | 2 | $0 (2024) |
| Cumberland Pharmaceuticals, Inc. | $40.15 | 2 | $0 (2024) |
| Amarin Pharma Inc. | $40.00 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $454.19 | 18 | Amgen Inc. ($92.44) |
| 2023 | $264.39 | 13 | Lilly USA, LLC ($137.97) |
| 2022 | $237.04 | 10 | Lilly USA, LLC ($91.26) |
| 2021 | $227.51 | 12 | Lilly USA, LLC ($79.95) |
| 2020 | $82.09 | 5 | Merck Sharp & Dohme Corporation ($38.06) |
| 2019 | $77.69 | 5 | AstraZeneca Pharmaceuticals LP ($77.69) |
| 2018 | $136.19 | 7 | AstraZeneca Pharmaceuticals LP ($57.65) |
| 2017 | $49.98 | 3 | Indivior Inc. ($19.62) |
All Payment Transactions
73 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/08/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $22.69 | General |
| Category: Diabetes | ||||||
| 10/31/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $22.16 | General |
| Category: VACCINES | ||||||
| 10/28/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $26.98 | General |
| Category: Biological | ||||||
| 09/11/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $30.29 | General |
| Category: RESPIRATORY | ||||||
| 08/23/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $25.51 | General |
| Category: Biological | ||||||
| 08/09/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $33.68 | General |
| Category: Inflammation | ||||||
| 07/26/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $25.30 | General |
| Category: Oncology | ||||||
| 06/25/2024 | Cumberland Pharmaceuticals, Inc. | KRISTALOSE (Drug) | Food and Beverage | In-kind items and services | $21.97 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/06/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $27.27 | General |
| Category: Diabetes | ||||||
| 05/30/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $20.80 | General |
| Category: Biological | ||||||
| 05/25/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $24.89 | General |
| Category: Oncology | ||||||
| 05/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $20.80 | General |
| Category: Respiratory | ||||||
| 03/28/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $31.91 | General |
| Category: Inflammation | ||||||
| 02/23/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $21.10 | General |
| Category: Respiratory | ||||||
| 02/15/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $26.85 | General |
| Category: Inflammation | ||||||
| 02/08/2024 | Cumberland Pharmaceuticals, Inc. | KRISTALOSE (Drug) | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/06/2024 | Gilead Sciences, Inc. | Epclusa (Drug) | Food and Beverage | In-kind items and services | $29.40 | General |
| Category: HCV | ||||||
| 01/25/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $24.41 | General |
| Category: Respiratory | ||||||
| 11/07/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: Diabetes | ||||||
| 10/27/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $22.72 | General |
| Category: Oncology | ||||||
| 10/18/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $23.47 | General |
| Category: VACCINES | ||||||
| 08/22/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $22.38 | General |
| Category: Diabetes | ||||||
| 06/30/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: Diabetes | ||||||
| 06/01/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: Diabetes | ||||||
| 05/03/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.68 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 456 | 710 | $94,107 | $44,797 |
| 2022 | 6 | 303 | 526 | $77,616 | $39,048 |
| 2021 | 12 | 491 | 1,018 | $98,490 | $56,061 |
| 2020 | 11 | 575 | 1,300 | $132,215 | $63,868 |
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 84 | 233 | $50,448 | $22,779 | 45.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 76 | 148 | $22,900 | $10,782 | 47.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 41 | 41 | $9,370 | $6,108 | 65.2% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2023 | 36 | 36 | $1,465 | $1,084 | 74.0% |
| 96136 | Administration of psychological or neuropsychological test, first 30 minutes | Office | 2023 | 29 | 29 | $2,145 | $1,084 | 50.5% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 43 | 43 | $1,715 | $927.51 | 54.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 67 | 97 | $2,060 | $807.80 | 39.2% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 35 | 35 | $1,315 | $754.95 | 57.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 33 | 34 | $2,414 | $425.32 | 17.6% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 12 | 14 | $275.00 | $44.94 | 16.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 86 | 253 | $40,095 | $17,894 | 44.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 71 | 120 | $25,429 | $13,946 | 54.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 37 | 37 | $8,672 | $5,671 | 65.4% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 41 | 41 | $1,650 | $894.67 | 54.2% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2022 | 15 | 15 | $610.00 | $464.92 | 76.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 53 | 60 | $1,160 | $177.18 | 15.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 93 | 333 | $49,982 | $25,443 | 50.9% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time per calendar month | Office | 2021 | 58 | 312 | $18,720 | $11,715 | 62.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 47 | 47 | $9,437 | $7,320 | 77.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 28 | 36 | $7,200 | $4,354 | 60.5% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2021 | 53 | 53 | $2,650 | $1,709 | 64.5% |
| 0012A | Adm sarscov2 100mcg/0.5ml2nd | Office | 2021 | 32 | 32 | $1,600 | $1,524 | 95.3% |
| 0011A | Adm sarscov2 100mcg/0.5ml1st | Office | 2021 | 27 | 27 | $1,350 | $1,286 | 95.3% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 43 | 43 | $2,150 | $968.36 | 45.0% |
| 0013A | Fee covid-19 vac 2 booster | Office | 2021 | 18 | 18 | $900.00 | $857.52 | 95.3% |
About Dr. Diogenes Almonte, MD
Dr. Diogenes Almonte, MD is a Pediatrics healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/09/2007. The National Provider Identifier (NPI) number assigned to this provider is 1861606014.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Diogenes Almonte, MD has received a total of $1,529 in payments from pharmaceutical and medical device companies, with $454.19 received in 2024. These payments were reported across 73 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($1,529).
As a Medicare-enrolled provider, Almonte has provided services to 1,825 Medicare beneficiaries, totaling 3,554 services with total Medicare billing of $203,775. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Practice Information
- Specialty Pediatrics
- Location Brooklyn, NY
- Active Since 05/09/2007
- Last Updated 12/22/2015
- Taxonomy Code 208000000X
- Entity Type Individual
- NPI Number 1861606014
Products in Payments
- MOUNJARO (Drug) $254.19
- MAVYRET (Drug) $111.91
- FARXIGA (Drug) $107.01
- SYMBICORT (Drug) $94.38
- Otezla (Drug) $92.44
- Cologuard Collection Kit (Device) $90.01
- JARDIANCE (Drug) $80.07
- Veozah (Drug) $73.29
- AIRSUPRA (Drug) $66.31
- BEVESPI AEROSPHERE (Drug) $57.65
- PREVNAR 20 (Biological) $45.63
- SYNTHROID (Drug) $45.21
- KRISTALOSE (Drug) $40.15
- Vascepa (Drug) $40.00
- TRULICITY (Drug) $39.79
- ImmunoCAP (Device) $38.54
- JANUVIA (Drug) $38.06
- TRELEGY ELLIPTA (Drug) $30.29
- Epclusa (Drug) $29.40
- Dayvigo (Drug) $24.23
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatrics Doctors in Brooklyn
Warren Seigel
Pediatrics — Payments: $147,615
Dr. Patrick Schnell, M.d, M.D
Pediatrics — Payments: $135,686
Dr. Howard Levine, M.d, M.D
Pediatrics — Payments: $134,944
Dr. Jeannette Jakus, Md, MD
Pediatrics — Payments: $46,151
Dr. Sherry Sakowitz, M.d, M.D
Pediatrics — Payments: $26,796
Dr. Steven Schwarz, Md, MD
Pediatrics — Payments: $25,014